QUOTED. 14 December. Kevin Sayer.
Dexcom’s management outlines its three-pronged growth strategy to reach $4-$4.5bn in revenues by 2025 during its recent investor day meeting. See what Dexcom’s CEO Kevin Sayer about it here.
“We really believe there will come a day in the US when people won’t be on finger sticks any more. This technology will be everywhere in the marketplace.” – Kevin Sayer, CEO, Dexcom
- Find out more: Dexcom Outlines Three-Pronged Growth Strategy To Reach $4.-4.5BN Revenue Goal By 2025
Click here for a free trial of Medtech Insight